KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Abbott Laboratories (ABT) Other Gross PP&E Adjustments (2016 - 2025)

Abbott Laboratories' Other Gross PP&E Adjustments history spans 17 years, with the latest figure at -$585.0 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 6.95% year-over-year to -$585.0 million; the TTM value through Dec 2025 reached -$585.0 million, down 6.95%, while the annual FY2025 figure was -$585.0 million, 6.95% down from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was -$585.0 million at Abbott Laboratories, down from $23.1 billion in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $23.1 billion in Q3 2025 and bottomed at -$1.2 billion in Q4 2021.
  • The 5-year median for Other Gross PP&E Adjustments is $19.0 billion (2021), against an average of $14.7 billion.
  • The largest YoY upside for Other Gross PP&E Adjustments was 47.53% in 2022 against a maximum downside of 10.3% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.2 billion in 2021, then soared by 47.53% to -$605.0 million in 2022, then increased by 1.98% to -$593.0 million in 2023, then grew by 7.76% to -$547.0 million in 2024, then fell by 6.95% to -$585.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Other Gross PP&E Adjustments are -$585.0 million (Q4 2025), $23.1 billion (Q3 2025), and $22.8 billion (Q2 2025).